LGHT vs. IBB ETF Comparison

Comparison of Langar Global HealthTech ETF (LGHT) to iShares Nasdaq Biotechnology Index Fund (IBB)

LGHT

Langar Global HealthTech ETF

LGHT Description

LGHT targets the global healthcare technology industry. The fund actively invests in HealthTech companies, which the adviser defines as firms that develop technology designed to create healthcare efficiency by addressing key pain points for patients, providers, payors, and hospitals, including those companies that derive a majority of their revenue from HealthTech products and services. The portfolio construction starts by identifying companies that fit into the advisers HealthTech definition. The remaining companies are screened using a proprietary metric that assesses each firms financial health, involvement in relevant controversies, as well as the strength of its team and culture. Each company is then assigned an industry risk score through an algorithm that defines quantitative and qualitative risk categories and weights them accordingly. Finally, each company is reviewed by an investment committee. However, the portfolio manager still has full discretion over the final selection.

Grade (RS Rating)

Last Trade

$10.63

Average Daily Volume

374

Number of Holdings ^*

8

* may have additional holdings in another (foreign) market

IBB

iShares Nasdaq Biotechnology Index Fund

IBB Description

The investment seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index contains securities of NASDAQ® listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by The NASDAQ OMX Group, Inc. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$144.77

Average Daily Volume

1,131,268

Number of Holdings ^*

10

* may have additional holdings in another (foreign) market

Performance

Period	LGHT	IBB
30 Days	0.34%	-2.29%
60 Days	6.26%	0.42%
90 Days	4.35%	7.17%
12 Months		20.11%

1 Overlapping Holdings

	Symbol	Grade	Weight in LGHT	Weight in IBB	Overlap
	IQV	F	5.91%	4.17%	4.17%

LGHT Overweight 7 Positions Relative to IBB

	Symbol	Grade	Weight
	ISRG	C	22.61%
	GEHC	B	6.69%
	DXCM	F	5.93%
	RMD	C	5.43%
	PHG	A	5.04%
	VEEV	C	4.53%
	ZBH	F	3.58%

LGHT Underweight 9 Positions Relative to IBB

	Symbol	Grade	Weight
	GILD	A	-8.92%
	REGN	D	-8.77%
	AMGN	D	-7.92%
	VRTX	D	-7.9%
	ALNY	B	-3.09%
	MTD	B	-2.83%
	BIIB	F	-2.77%
	ARGX	A	-2.45%
	MRNA	F	-2.44%

LGHT: Top Represented Industries & Keywords

Industries: Diagnostics & Research Medical Instruments & Supplies Health Information Services Health Information Services Medical Devices

Keywords: S&P 500 Medicine Nasdaq 100 Healthcare Dealers Healthcare Providers Magnetic Resonance Imaging Surgery Telehealth Telemedicine 3 D Aesthetics Artificial Intelligence In Healthcare Beauty Products Beverage Appliances Biopharmaceutical Development Blood Glucose Monitoring Bone Breathing CRM Camera

IBB: Top Represented Industries & Keywords

Industries: Biotechnology Drug Manufacturers - Major Diagnostics & Research

Keywords: S&P 500 Nasdaq 100 Biotechnology Biopharmaceutical Inflammation Medicine Life Sciences Autoimmune Disease Bone Breakthrough Therapy Cancer Cardiovascular Disease Cholesterol Clinical Development Coronavirus Cystic Fibrosis Hemophilia Immunology Infection Influenza